• DNA Cell Cycle Analysis by Flow Cytometry
  • IMMray, PanCan-d Test for Early Detection of Pancreatic Cancer
  • Methylation Cancer Marker Detection in Cell-free Circulating Tumor DNA (Northstar Select and Response™)
  • MSH2 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • Dihydropyrimidine Dehydrogenase (DPYD) Genotyping
  • Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
  • Cancer Antigen (CA) 19-9, Serum
  • Chronic liver disease
  • Partner and Localizer of BRCA2 (PALB2) Gene Mutation Analysis
  • Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoExTra (Oncomap™ ExTra) for Metastatic Cancer
Medical Test

Overview
Access to OncoExTra (Oncomap™ ExTra) for Metastatic Cancer is restricted.
Loading...